CVS vs CI — Key Metrics

Metric CVS (CVS HEALTH CORP) CI (CIGNA GROUP)
Price81.35285.37
Market Cap104.09 Billion75.2 Billion
P/E (TTM)9.3812.53
P/B (Quarterly)1.2711.831
P/S (TTM)0.250.26
Net Profit Margin (TTM)2.62.1
Gross Margin (TTM)14.29.1
ROE (TTM)14.114.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

CVS HEALTH CORP
vs
 
CIGNA GROUP
 
CVS HEALTH CORP
vs
 
CIGNA GROUP
Performance Comparison
AI Model Recommendation
CVS · CVS HEALTH CORP

Outperform

50
UnderperformOutperform
CI · CIGNA GROUP

Greatly Outperform

85
UnderperformOutperform
Recommendation Summary

Stock CVS is projected to outperform the market, stock CI is projected to greatly outperform the market. Upfront Recommendation: CI.

Financial Metrics
Prices delayed ~15 min
CVS Metrics CI
$81.35 Price $285.37
— Market Capitalization —
9.38 Price to Earnings Ratio 12.53
0.25 Price to Sales 0.26
6.69 Price to FCF Ratio 9.1
1.74 Price to Gross Profit 2.89
1.31 Price to Current Assets 1.59

CVS vs CI at a glance

CVS Health Corp (CVS) and Cigna Group (CI) are both Healthcare Plans companies in the Healthcare sector. CVS is the larger, at $104.1 billion in market value against $75.2 billion for CI, about 1.4 times the size.

On trailing-twelve-month figures, CVS trades at 9.4 times trailing earnings and CI at 12.5; net profit margins are 2.6% and 2.1%.

The Upfront Investment model currently rates CVS Outperform and CI Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.